EMCDDA logo Annual report on the state of the drugs problem in the European Union 2001

Home of the Annual Report
Introduction to the annual report
Chapter 1: Drug demand and drug supply
Chapter 2: Responses to drug use
Chapter 3: Selected issues
Chapter 4: The drugs problem in central and eastern European countries
Situation and trends
Policy and institutional
Money laundering
Figures and tables
Download complete report in 12 languages  in Adobe PDF  format
News Releases and press information

Search Site Map Contact


Money laundering

The majority of the candidate central and east European countries have implemented anti-money laundering measures. Almost all of them have established a legal, institutional and judicial anti-money laundering framework and a financial intelligence unit either became operational or was further strengthened in the last two years. Furthermore, most of these units have formally been accepted as full Egmont Group(32) members and may thus be considered as both complete in compliance with the EU standards and practices, and to a large extent able to fulfil their future obligations towards the EU.

New anti-money laundering legislation came into force in Romania in 1999 and was passed by the Parliament in Slovakia and Poland in 2000. In 1999, the Bulgarian Law on Banks was amended and an amendment to the money laundering act entered into force in the Czech Republic in 2000.

(32) The Egmont Group is an informal organisation established in 1995 with the goal of providing a forum for financial intelligence units (FIUs) to improve support to their respective national anti-money laundering programmes. Currently 53 FIUs are members of the group.



Despite the fact that, in general, the legal and institutional framework in the CEECs is in place, the overall capacities to implement the adopted measures effectively, as well as the resources allocated, remain on the whole limited. The low operational level of the national coordination mechanisms in some countries obstructs the effectiveness of policy implementation and there is a deficiency in regional cooperation. In most countries, this affects the capacity of the institutions concerned to tackle the problem and constrains their ability to participate effectively in international cooperation measures designed to deal with the trans-frontier threats with which both the CEECs and the EU are faced. It is therefore essential that the countries concerned continue to reinforce their policies, institutions and coordination mechanisms and allocate the necessary resources to achieve this. To further boost this process in 2000, the European Commission allocated an additional EUR 1 million to each candidate country for the purpose of developing a specific drug component in their national Phare programmes. Most of these projects will be developed through twinning with EU Member States.



Situation and trends | Policy and institutional responses | Money laundering
EMCDDA 2001 | home | webmaster | disclaimer